Ningbo Menovo Pharmaceutical Co (SHSE:603538) ROCE % : 3.63% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ningbo Menovo Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ningbo Menovo Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 3.63%.

Ningbo Menovo Pharmaceutical Co ROCE % Historical Data

The historical data trend for Ningbo Menovo Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ningbo Menovo Pharmaceutical Co ROCE % Chart

Ningbo Menovo Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.87

12.22

8.55

13.84

1.21

Ningbo Menovo Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															7.96	-1.74	3.75	-5.16	3.63

Ningbo Menovo Pharmaceutical Co ROCE % Calculation

Ningbo Menovo Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	37.018	/	( ( (4419.493 - 1362.219)	+	(4423.516 - 1378.267) )	/ 2 )
	=	37.018	/	( (3057.274	+	3045.249)	/ 2 )
	=	37.018	/	3051.2615
	=	1.21 %

Ningbo Menovo Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	110.472	/	( ( (4423.516 - 1378.267)	+	(4344.246 - 1295.755) )	/ 2 )
	=	110.472	/	( ( 3045.249	+	3048.491 )	/ 2 )
	=	110.472	/	3046.87
	=	3.63 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Ningbo Menovo Pharmaceutical Co (SHSE:603538) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ningbo Menovo Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Ningbo Menovo Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ningbo Menovo Pharmaceutical Co Ltd (SHSE:603538) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040

Website

http://www.menovopharm.com

Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.

Executives

Xu Jian	senior management
Cao Qian	Director
Yao Fang	Director
Ying Gao Feng	Director
Sun Yan	Director
Shi Jian Xiang	Director
Wu Feng Yun	Director
Tu Ying	Director
Yao Cheng Zhi	Director
Zheng Hui Lin	Supervisors
Jiao Hua	senior management

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Headlines

No Headlines